Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results
Company to Host Conference Call on Tuesday, February 25, 2025 at 8:30 am ETLEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a...
Day: January 28, 2025
Persephone Biosciences Announces Full Enrollment in AMBROSIA Food as Medicine Study
- 400 participants with a medium-to-high risk of developing colorectal cancer (CRC) have been enrolled across two arms - -...
Precision Optics Launches Revolutionary Unity Imaging Platform
GARDNER, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation (Nasdaq: POCI), a global leader in the design and...
Sharps Technology, Inc. Announces Pricing of Upsized $20.0 Million Underwritten Public Offering
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and...
Intelligent Bio Solutions Partners with IVY Diagnostics to Expand in Europe’s $3.6 Billion Drug Screening Market and in Middle Eastern Regions
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical...
Better Choice Company Signs Non-Binding Term Sheet to Sell Halo Asia for $6.5 Million in Cash at Closing and a 5-Year Royalty Valued at a Minimum of $1.65 Million
Upon closing, Better Choice will retain ownership of North American and rest-of-world ex Asia operations Buyer has paid a $500,000...
BioAge Labs Announces Company Updates on APJ, NLRP3, and Platform Programs
Advancement of next-generation APJ agonists with discontinuation of azelaprag Nomination of NLRP3 inhibitor BGE-102 as a development candidate, with initial...
New Survey from Aeroflow Sleep Reveals Disparities Around Women’s Sleep Health
The proprietary survey found 60% of women feel their sleep is negatively impacting their day-to-day activities, yet more than half...
Progyny, Inc. Enhances Suite of Services with Acquisition of BenefitBump
Provides expecting parents with a concierge-level service model that delivers expert guidance, navigation and support for parental leave planningNEW YORK,...
Allogene Therapeutics Secures U.S. FDA IND Clearance for ALLO-329, Advancing its Next-Generation Allogeneic CAR T into Autoimmune Diseases
Dual-Targeted CD19/CD70 Allogeneic CAR T: Best-in-Class Design to Enhance Therapeutic Benefit and Expand Treatment Potential Across a Range of Autoimmune...
Eterna Therapeutics Announces Expansion of Scientific Advisory Board
Dr. Jerome Zeldis and Dr. Blythe Sather bring exceptional backgrounds in cell therapy and solid tumorsCAMBRIDGE, Mass., Jan. 28, 2025...
Silexion Therapeutics Reports Strong Tumor Growth Reduction from Systemic Administration of SIL-204 in Preclinical Pancreatic Cancer Models
New preclinical findings provide validation for Silexion’s new systemic administration approach for SIL-204, demonstrating inhibition of tumor growth in a...
Polarean and SimonMed Announce Collaboration to Advance Lung Imaging Innovation
One of the largest US outpatient medical imaging providers to introduce Xenon MRI platform to its network Polarean and SimonMed...
Evaxion granted 180-day compliance extension by Nasdaq as it restores equity above minimum requirement
Following a constructive Nasdaq hearing panel on January 7, 2025, Evaxion has been granted a 180-day extension in relation to...
FOXO TECHNOLOGIES, INC., PROVIDES UPDATE ON RECENT ACOMPLISHMENTS AND BUSINESS STRATEGY
MINNEAPOLIS, MN, Jan. 28, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), provides a brief shareholder letter from Seamus...
60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis
Investigational Review Board (IRB) approval has been granted for the open-label study to evaluate tafenoquine for treatment of patients with...
March Biosciences Receives FDA Orphan Drug Designation for MB-105, a First-in-Class CD5 CAR-T Cell Therapy, for T-Cell Lymphoma
Company prepares to advance to Phase 2 clinical trial in early 2025 HOUSTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- March...
Lighthouse Autism Center Announces New Location in South Sioux City, Nebraska, creating 35 Jobs and Serving 25 Families
Leading ABA Provider Set to Open Newest Location in South Sioux City, NE Therapy Room at LAC Therapy Room at...
Zenas BioPharma to Present at the Guggenheim SMID Cap Biotech Conference
WALTHAM, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global...
Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer
Appoints Simon Harnest as Chief Financial Officer to advance capital markets and corporate development strategy supporting TOS-358, the Company’s lead...